Kidney Cancer Treatment Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 71 pages | ID: KE4C1180D635EN
Market Monitor Global

Abstracts

Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.

This report contains market size and forecasts of Kidney Cancer Treatment Drugs in global, including the following market information:

Global Kidney Cancer Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Kidney Cancer Treatment Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Kidney Cancer Treatment Drugs companies in 2021 (%)

The global Kidney Cancer Treatment Drugs market was valued at 5255.3 million in 2021 and is projected to reach US$ 6545.8 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Angiogenesis Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Kidney Cancer Treatment Drugs include Amgen/Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Kidney Cancer Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney Cancer Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• Angiogenesis Inhibitors
• mTOR Inhibitors
• Monoclonal Antibodies
• Cytokine Immunotherapy (IL-2)

Global Kidney Cancer Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney Cancer Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Global Kidney Cancer Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Kidney Cancer Treatment Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Kidney Cancer Treatment Drugs revenues share in global market, 2021 (%)

Key companies Kidney Cancer Treatment Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Kidney Cancer Treatment Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen/Allergan
• Argos Therapeutics
• AstraZeneca
• Aveo Pharmaceuticals
• Bayer
• Exelixis
• Incyte
• Merck
• Roche
• Pfizer
• Bristol-Myers Squibb
• Eisai
• Prometheus Labs
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Kidney Cancer Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Kidney Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KIDNEY CANCER TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Kidney Cancer Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Kidney Cancer Treatment Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Kidney Cancer Treatment Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Kidney Cancer Treatment Drugs Players in Global Market
3.2 Top Global Kidney Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Kidney Cancer Treatment Drugs Revenue by Companies
3.4 Global Kidney Cancer Treatment Drugs Sales by Companies
3.5 Global Kidney Cancer Treatment Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Kidney Cancer Treatment Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Kidney Cancer Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Cancer Treatment Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Kidney Cancer Treatment Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Kidney Cancer Treatment Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Kidney Cancer Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 Angiogenesis Inhibitors
  4.1.3 mTOR Inhibitors
  4.1.4 Monoclonal Antibodies
  4.1.5 Cytokine Immunotherapy (IL-2)
4.2 By Type - Global Kidney Cancer Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Kidney Cancer Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Kidney Cancer Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Kidney Cancer Treatment Drugs Sales & Forecasts
  4.3.1 By Type - Global Kidney Cancer Treatment Drugs Sales, 2017-2022
  4.3.2 By Type - Global Kidney Cancer Treatment Drugs Sales, 2023-2028
  4.3.3 By Type - Global Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Kidney Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Kidney Cancer Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Research Institutes
  5.1.4 Diagnostic Centers
  5.1.5 Others
5.2 By Application - Global Kidney Cancer Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Kidney Cancer Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Kidney Cancer Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Kidney Cancer Treatment Drugs Sales & Forecasts
  5.3.1 By Application - Global Kidney Cancer Treatment Drugs Sales, 2017-2022
  5.3.2 By Application - Global Kidney Cancer Treatment Drugs Sales, 2023-2028
  5.3.3 By Application - Global Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Kidney Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Kidney Cancer Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Kidney Cancer Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Kidney Cancer Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Kidney Cancer Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Kidney Cancer Treatment Drugs Sales & Forecasts
  6.3.1 By Region - Global Kidney Cancer Treatment Drugs Sales, 2017-2022
  6.3.2 By Region - Global Kidney Cancer Treatment Drugs Sales, 2023-2028
  6.3.3 By Region - Global Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Kidney Cancer Treatment Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Kidney Cancer Treatment Drugs Sales, 2017-2028
  6.4.3 US Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.4.4 Canada Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.4.5 Mexico Kidney Cancer Treatment Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Kidney Cancer Treatment Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Kidney Cancer Treatment Drugs Sales, 2017-2028
  6.5.3 Germany Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.5.4 France Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.5.5 U.K. Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.5.6 Italy Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.5.7 Russia Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.5.9 Benelux Kidney Cancer Treatment Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Kidney Cancer Treatment Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Kidney Cancer Treatment Drugs Sales, 2017-2028
  6.6.3 China Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.6.4 Japan Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.6.5 South Korea Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.6.7 India Kidney Cancer Treatment Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Kidney Cancer Treatment Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Kidney Cancer Treatment Drugs Sales, 2017-2028
  6.7.3 Brazil Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.7.4 Argentina Kidney Cancer Treatment Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales, 2017-2028
  6.8.3 Turkey Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.8.4 Israel Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Kidney Cancer Treatment Drugs Market Size, 2017-2028
  6.8.6 UAE Kidney Cancer Treatment Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Amgen/Allergan
  7.1.1 Amgen/Allergan Corporate Summary
  7.1.2 Amgen/Allergan Business Overview
  7.1.3 Amgen/Allergan Kidney Cancer Treatment Drugs Major Product Offerings
  7.1.4 Amgen/Allergan Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Amgen/Allergan Key News
7.2 Argos Therapeutics
  7.2.1 Argos Therapeutics Corporate Summary
  7.2.2 Argos Therapeutics Business Overview
  7.2.3 Argos Therapeutics Kidney Cancer Treatment Drugs Major Product Offerings
  7.2.4 Argos Therapeutics Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Argos Therapeutics Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Kidney Cancer Treatment Drugs Major Product Offerings
  7.3.4 AstraZeneca Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Aveo Pharmaceuticals
  7.4.1 Aveo Pharmaceuticals Corporate Summary
  7.4.2 Aveo Pharmaceuticals Business Overview
  7.4.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Major Product Offerings
  7.4.4 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Aveo Pharmaceuticals Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Kidney Cancer Treatment Drugs Major Product Offerings
  7.5.4 Bayer Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Bayer Key News
7.6 Exelixis
  7.6.1 Exelixis Corporate Summary
  7.6.2 Exelixis Business Overview
  7.6.3 Exelixis Kidney Cancer Treatment Drugs Major Product Offerings
  7.6.4 Exelixis Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Exelixis Key News
7.7 Incyte
  7.7.1 Incyte Corporate Summary
  7.7.2 Incyte Business Overview
  7.7.3 Incyte Kidney Cancer Treatment Drugs Major Product Offerings
  7.7.4 Incyte Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Incyte Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Kidney Cancer Treatment Drugs Major Product Offerings
  7.8.4 Merck Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Merck Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Kidney Cancer Treatment Drugs Major Product Offerings
  7.9.4 Roche Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Roche Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Kidney Cancer Treatment Drugs Major Product Offerings
  7.10.4 Pfizer Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Pfizer Key News
7.11 Bristol-Myers Squibb
  7.11.1 Bristol-Myers Squibb Corporate Summary
  7.11.2 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Business Overview
  7.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Major Product Offerings
  7.11.4 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.11.5 Bristol-Myers Squibb Key News
7.12 Eisai
  7.12.1 Eisai Corporate Summary
  7.12.2 Eisai Kidney Cancer Treatment Drugs Business Overview
  7.12.3 Eisai Kidney Cancer Treatment Drugs Major Product Offerings
  7.12.4 Eisai Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.12.5 Eisai Key News
7.13 Prometheus Labs
  7.13.1 Prometheus Labs Corporate Summary
  7.13.2 Prometheus Labs Kidney Cancer Treatment Drugs Business Overview
  7.13.3 Prometheus Labs Kidney Cancer Treatment Drugs Major Product Offerings
  7.13.4 Prometheus Labs Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.13.5 Prometheus Labs Key News
7.14 Novartis
  7.14.1 Novartis Corporate Summary
  7.14.2 Novartis Business Overview
  7.14.3 Novartis Kidney Cancer Treatment Drugs Major Product Offerings
  7.14.4 Novartis Kidney Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.14.5 Novartis Key News

8 GLOBAL KIDNEY CANCER TREATMENT DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Kidney Cancer Treatment Drugs Production Capacity, 2017-2028
8.2 Kidney Cancer Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Cancer Treatment Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 KIDNEY CANCER TREATMENT DRUGS SUPPLY CHAIN ANALYSIS

10.1 Kidney Cancer Treatment Drugs Industry Value Chain
10.2 Kidney Cancer Treatment Drugs Upstream Market
10.3 Kidney Cancer Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Kidney Cancer Treatment Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Kidney Cancer Treatment Drugs in Global Market
Table 2. Top Kidney Cancer Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Kidney Cancer Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Kidney Cancer Treatment Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Kidney Cancer Treatment Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Kidney Cancer Treatment Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Kidney Cancer Treatment Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Kidney Cancer Treatment Drugs Product Type
Table 9. List of Global Tier 1 Kidney Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Kidney Cancer Treatment Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Kidney Cancer Treatment Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Kidney Cancer Treatment Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Kidney Cancer Treatment Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Kidney Cancer Treatment Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Kidney Cancer Treatment Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Kidney Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Kidney Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Kidney Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Kidney Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Kidney Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Kidney Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Kidney Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Kidney Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 46. Amgen/Allergan Corporate Summary
Table 47. Amgen/Allergan Kidney Cancer Treatment Drugs Product Offerings
Table 48. Amgen/Allergan Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Argos Therapeutics Corporate Summary
Table 50. Argos Therapeutics Kidney Cancer Treatment Drugs Product Offerings
Table 51. Argos Therapeutics Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Kidney Cancer Treatment Drugs Product Offerings
Table 54. AstraZeneca Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Aveo Pharmaceuticals Corporate Summary
Table 56. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Offerings
Table 57. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer Kidney Cancer Treatment Drugs Product Offerings
Table 60. Bayer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Exelixis Corporate Summary
Table 62. Exelixis Kidney Cancer Treatment Drugs Product Offerings
Table 63. Exelixis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Incyte Corporate Summary
Table 65. Incyte Kidney Cancer Treatment Drugs Product Offerings
Table 66. Incyte Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Kidney Cancer Treatment Drugs Product Offerings
Table 69. Merck Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Roche Corporate Summary
Table 71. Roche Kidney Cancer Treatment Drugs Product Offerings
Table 72. Roche Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Kidney Cancer Treatment Drugs Product Offerings
Table 75. Pfizer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Bristol-Myers Squibb Corporate Summary
Table 77. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Offerings
Table 78. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Eisai Corporate Summary
Table 80. Eisai Kidney Cancer Treatment Drugs Product Offerings
Table 81. Eisai Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Prometheus Labs Corporate Summary
Table 83. Prometheus Labs Kidney Cancer Treatment Drugs Product Offerings
Table 84. Prometheus Labs Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Novartis Corporate Summary
Table 86. Novartis Kidney Cancer Treatment Drugs Product Offerings
Table 87. Novartis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Kidney Cancer Treatment Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Kidney Cancer Treatment Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Kidney Cancer Treatment Drugs Production by Region, 2017-2022 (K Units)
Table 91. Global Kidney Cancer Treatment Drugs Production by Region, 2023-2028 (K Units)
Table 92. Kidney Cancer Treatment Drugs Market Opportunities & Trends in Global Market
Table 93. Kidney Cancer Treatment Drugs Market Drivers in Global Market
Table 94. Kidney Cancer Treatment Drugs Market Restraints in Global Market
Table 95. Kidney Cancer Treatment Drugs Raw Materials
Table 96. Kidney Cancer Treatment Drugs Raw Materials Suppliers in Global Market
Table 97. Typical Kidney Cancer Treatment Drugs Downstream
Table 98. Kidney Cancer Treatment Drugs Downstream Clients in Global Market
Table 99. Kidney Cancer Treatment Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Kidney Cancer Treatment Drugs Segment by Type
Figure 2. Kidney Cancer Treatment Drugs Segment by Application
Figure 3. Global Kidney Cancer Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Kidney Cancer Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Kidney Cancer Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Kidney Cancer Treatment Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Cancer Treatment Drugs Revenue in 2021
Figure 9. By Type - Global Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Kidney Cancer Treatment Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Kidney Cancer Treatment Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 19. US Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 24. Germany Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 33. China Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Kidney Cancer Treatment Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Kidney Cancer Treatment Drugs by Region, 2021 VS 2028
Figure 50. Kidney Cancer Treatment Drugs Industry Value Chain
Figure 51. Marketing Channels